Kansas Business Today
SEE OTHER BRANDS

Your business and economy news reporter from Kansas

Superior Group of Companies Reports Third Quarter 2025 Results


– Total net sales of $138.5 million, compared to $149.7 million in prior year third quarter
– Net income of $2.7 million, compared to $5.4 million in prior year third quarter 
– EBITDA of $7.5 million, compared to $11.7 million in prior year third quarter
– Board of Directors approves $0.14 per share quarterly dividend –
 

ST. PETERSBURG, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its third quarter 2025 results.

“Our earnings were as expected, demonstrating solid sequential progress from the second quarter and our updated full-year outlook reflects a higher mid-point,” said Michael Benstock, Chief Executive Officer. “We were also able to meaningfully improve SG&A, which bodes well for future profitability as greater economic clarity emerges. For now, our enhanced selling capabilities and competitive advantages continue to drive growth in our business pipelines, even during this period of volatile trade policy and uncertainty for customers and prospects. We are leveraging our diverse supply base and offering alternative products and solutions, while also benefiting from our own diversity across business segments and the end markets we serve. With our strong balance sheet, we can invest for future growth while paying an attractive dividend as we work to create long-term shareholder value.”

Third Quarter Results

For the third quarter ended September 30, 2025, net sales were $138.5 million, compared to third quarter 2024 net sales of $149.7 million. Pretax earnings of $3.2 million compared to $6.6 million in the third quarter of 2024. Net earnings of $2.7 million or $0.18 per diluted share compared to net income of $5.4 million or $0.33 per diluted share for the third quarter of 2024.

Third Quarter 2025 Dividend

The Board of Directors declared a quarterly dividend of $0.14 per share, payable November 28, 2025 to shareholders of record as of November 14, 2025.

2025 Full-Year Outlook

The Company is updating its full-year revenue outlook range from $550 million to $575 million to $560 million to $570 million.

Webcast and Conference Call

The Company will host a webcast and conference call at 5:00 pm Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian toll-free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through November 17, 2025. To access the replay, dial 1-877-344-7529 in the United States or 1-412-317-0088 from international locations. Canadian dialers can access the replay at 855-669-9658. Please reference conference number 6514610 for replay access.

Disclosure Regarding Forward Looking Statements

Certain matters discussed in this press release are forward-looking statements intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential, or plan or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; the effect of existing and/or new or expanded tariffs, uncertainties related to supply disruptions, inflationary environment (including with respect to the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (U.S. or United States) in which the Companys customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the effect of the Companys previously disclosed material weakness in internal control over financial reporting; the Company may identify a material weakness in internal control in the future, which could result in us not preventing or detecting on a timely basis a material misstatement of the Companys financial statements and to maintain effective internal control over financial reporting; and other factors described in the Companys filings with the Securities and Exchange Commission, including those described in the Risk Factors section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

About Superior Group of Companies, Inc. (SGC):

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

Investor Relations Contact:
Investors@Superiorgroupofcompanies.com

 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except shares and per share data)
             
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2025     2024     2025     2024  
Net sales   $ 138,467     $ 149,690     $ 419,609     $ 420,268  
                                 
Costs and expenses:                                
Cost of goods sold     85,389       89,144       260,764       253,650  
Selling and administrative expenses     48,513       52,404       150,855       149,906  
Interest expense, net     1,378       1,569       3,873       4,897  
      135,280       143,117       415,492       408,453  
Income before income tax expense     3,187       6,573       4,117       11,815  
Income tax expense     443       1,170       580       1,900  
Net income   $ 2,744     $ 5,403     $ 3,537     $ 9,915  
                                 
Net income per share:                                
Basic   $ 0.19     $ 0.34     $ 0.24     $ 0.62  
Diluted   $ 0.18     $ 0.33     $ 0.23     $ 0.60  
                                 
Weighted average shares outstanding during the period:                                
Basic     14,738,863       16,107,549       15,050,834       16,118,885  
Diluted     15,119,050       16,543,990       15,422,144       16,588,914  
                                 
Cash dividends per common share   $ 0.14     $ 0.14     $ 0.42     $ 0.42  
                                 


 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except shares and par value data)
             
    September 30,     December 31,  
    2025     2024  
    (Unaudited)          
ASSETS                
Current assets:                
Cash and cash equivalents   $ 16,651     $ 18,766  
Accounts receivable, net     97,415       95,092  
Inventories     105,655       96,675  
Contract assets     48,623       51,688  
Prepaid expenses and other current assets     11,685       10,831  
Total current assets     280,029       273,052  
Property, plant and equipment, net     38,830       41,879  
Operating lease right-of-use assets     12,726       15,567  
Deferred tax asset     13,828       13,835  
Intangible assets, net     48,440       51,137  
Goodwill     2,434       2,304  
Other assets     18,985       17,360  
Total assets   $ 415,272     $ 415,134  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY                
Current liabilities:                
Accounts payable   $ 45,727     $ 50,942  
Other current liabilities     42,902       44,367  
Current portion of long-term debt     6,094       5,625  
Current portion of acquisition-related contingent liabilities     648       814  
Total current liabilities     95,371       101,748  
Long-term debt     93,906       80,410  
Long-term pension liability     13,614       13,315  
Long-term acquisition-related contingent liabilities     743       935  
Long-term operating lease liabilities     7,875       10,486  
Other long-term liabilities     9,927       9,384  
Total liabilities     221,436       216,278  
Shareholders’ equity:                
Preferred stock, $.001 par value - authorized 300,000 shares (none issued)     -       -  
Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding 15,968,792 and 16,484,921 shares, respectively     15       16  
Additional paid-in capital     84,541       84,060  
Retained earnings     112,561       120,139  
Accumulated other comprehensive loss, net of tax:     (3,281 )     (5,359 )
Total shareholders’ equity     193,836       198,856  
Total liabilities and shareholders’ equity   $ 415,272     $ 415,134  
                 


 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
       
    Nine Months Ended September 30,  
    2025     2024  
CASH FLOWS FROM OPERATING ACTIVITIES                
Net income   $ 3,537     $ 9,915  
Adjustments to reconcile net income to net cash provided by operating activities:                
Depreciation and amortization     9,157       9,872  
Inventory write-downs     1,793       1,893  
Credit loss expense     2,347       251  
Share-based compensation expense     3,916       2,905  
Change in fair value of acquisition-related contingent liabilities     659       363  
Non-cash operating lease expense     2,843       1,625  
Other, net     244       653  
Changes in assets and liabilities, net of acquisition of a business:                
Accounts receivable     (3,710 )     3,891  
Contract assets     3,326       (1,671 )
Inventories     (10,535 )     2,241  
Prepaid expenses and other current assets     (423 )     (1,292 )
Other assets     (1,692 )     (959 )
Accounts payable and other current liabilities     (10,636 )     (5,917 )
Payment of acquisition-related contingent liabilities     (791 )     (686 )
Other long-term liabilities     1,235       1,413  
Net cash provided by operating activities     1,270       24,497  
                 
CASH FLOWS FROM INVESTING ACTIVITIES                
Additions to property, plant and equipment     (3,407 )     (2,911 )
Net cash used in investing activities     (3,407 )     (2,911 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES                
Borrowings under revolving lines of credit     76,000       31,000  
Payments under revolving lines of credit     (58,000 )     (37,000 )
Payments of term loan     (4,218 )     (3,281 )
Payment of cash dividends     (6,713 )     (6,994 )
Payment of acquisition-related contingent liabilities     (226 )     (897 )
Proceeds received on exercise of stock options and payments for shares withheld for taxes     90       1,118  
Common shares repurchased and retired     (7,928 )     (6,346 )
Net cash used in financing activities     (995 )     (22,400 )
                 
Effect of currency exchange rates on cash     1,017       (709 )
Net decreases in cash and cash equivalents     (2,115 )     (1,523 )
Cash and cash equivalents balance, beginning of period     18,766       19,896  
Cash and cash equivalents balance, end of period   $ 16,651     $ 18,373  
                 


 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
NON-GAAP FINANCIAL MEASURES
(Unaudited)
(In thousands)
             
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2025     2024     2025     2024  
Net income   $ 2,744     $ 5,403     $ 3,537     $ 9,915  
Interest expense, net     1,378       1,569       3,873       4,897  
Income tax expense     443       1,170       580       1,900  
Depreciation and amortization     2,975       3,252       9,157       9,872  
Impairment charge     -       260       -       260  
EBITDA(1)   $ 7,540     $ 11,654     $ 17,147     $ 26,844  
EBITDA margin(1)     5.4 %     7.8 %     4.1 %     6.4 %
                                 

(1) EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense and depreciation and amortization expense. EBITDA margin is defined as EBITDA divided by net sales. The Company believes EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences and (iii) asset base (depreciation and amortization). The Company uses EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. EBITDA is not a measure of financial performance under GAAP.  EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate EBITDA are significant components in understanding and assessing the Company’s results of operations. The Company’s EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate EBITDA in the same manner.

 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS
(Unaudited)
(In thousands)
                                     
    Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Three Months Ended September 30, 2025:                                                
Net sales   $ 85,095     $ 31,520     $ 22,664     $ (812 )   $ -     $ 138,467  
Cost of goods sold     55,466       19,394       10,669       (140 )     -       85,389  
Gross margin     29,629       12,126       11,995       (672 )     -       53,078  
Selling and administrative expenses     23,501       9,779       10,283       (672 )     5,622       48,513  
Depreciation and amortization     1,396       832       661       -       86       2,975  
Segment EBITDA(1)   $ 7,524     $ 3,179     $ 2,373     $ -     $ (5,536 )   $ 7,540  
                                                 
    Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Three Months Ended September 30, 2024:                                                
Net sales   $ 92,547     $ 33,025     $ 25,038     $ (920 )   $ -     $ 149,690  
Cost of goods sold     59,037       19,216       11,296       (405 )     -       89,144  
Gross margin     33,510       13,809       13,742       (515 )     -       60,546  
Selling and administrative expenses     24,223       11,240       11,482       (515 )     5,974       52,404  
Impairment charge     -       260       -       -       -       260  
Depreciation and amortization     1,446       944       770       -       92       3,252  
Segment EBITDA(1)   $ 10,733     $ 3,773     $ 3,030     $ -     $ (5,882 )   $ 11,654  
                                                 
    Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Nine Months Ended September 30, 2025:                                                
Net sales   $ 264,216     $ 87,036     $ 70,866     $ (2,509 )   $ -     $ 419,609  
Cost of goods sold     173,884       54,761       33,277       (1,158 )     -       260,764  
Gross margin     90,332       32,275       37,589       (1,351 )     -       158,845  
Selling and administrative expenses     72,353       29,383       32,816       (1,351 )     17,654       150,855  
Depreciation and amortization     4,271       2,598       2,022       -       266       9,157  
Segment EBITDA(1)   $ 22,250     $ 5,490     $ 6,795     $ -     $ (17,388 )   $ 17,147  
                                                 
    Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Nine Months Ended September 30, 2024:                                                
Net sales   $ 260,911     $ 88,854     $ 73,422     $ (2,919 )   $ -     $ 420,268  
Cost of goods sold     167,534       53,335       34,075       (1,294 )     -       253,650  
Gross margin     93,377       35,519       39,347       (1,625 )     -       166,618  
Selling and administrative expenses     70,486       30,931       32,436       (1,625 )     17,678       149,906  
Impairment charge     -       260       -       -       -       260  
Depreciation and amortization     4,513       2,837       2,246       -       276       9,872  
Segment EBITDA(1)   $ 27,404     $ 7,685     $ 9,157     $ -     $ (17,402 )   $ 26,844  
                                                 

(1) Segment EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment EBITDA include: interest expense, net and depreciation and amortization expense. Total EBITDA is a non-GAAP financial measure. Please see reconciliation of Total EBITDA included in the Non-GAAP Financial Measures table above.


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions